Developmental glaucoma aggravated by topical steroids.
D000287:Administration, Topical; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002924:Ciliary Body / Q000601:surgery; D003231:Conjunctivitis / Q000188:drug therapy; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005901:Glaucoma / Q000139:chemically induced* / Q000601:surgery; D005938:Glucocorticoids; D006068:Gonioscopy; D006801:Humans; D007498:Iris / Q000601:surgery; D008297:Male; D008916:Miotics / Q000627:therapeutic use; D009887:Ophthalmoscopy; D011183:Postoperative Complications; D014207:Trephining; D014792:Visual Acuity; D014794:Visual Fields
D000893:Anti-Inflammatory Agents; D002257:Carbonic Anhydrase Inhibitors; D005938:Glucocorticoids; D008916:Miotics; D003907:Dexamethasone